Open an Account
search icon
4
NOTIFICATIONS
Best Algo trading app in India
Bigul

Supriya Lifescience Ltd - 543434 - Appointment Of Whole Time Director And Key Managerial Personnel

 Pursuant to regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,2015, this is to inform you that the Board of Directors of the Company at their meeting held on May 26, 2023 have appointed Mr. Balasaheb Sawant as an Additional Director in the capacity of Whole Time Director and Key Managerial Personnel of the Company w.e.f. May 26, 2023 for a period of three years, subject to approval of the shareholders and the Central Government as may be applicable.
26-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Resignation of Director

 Pursuant to regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations,2015, it is hereby informed that Mr. Manoj Dorlikar, Whole Time Director and Key Managerial Personnel of the Company, has tendered his resignation with effect from May 26, 2023, due to the personal reason.
26-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Audited Financial Results For The Quarter And Year Ended March 31, 2023 (Revised)

 We hereby enclose the following: 1. Copy of the Revised Audited Financial Results of the Company for the Quarter And Year Ended March 31, 2023 along with the Limited Review report issued by Statutory Auditor;
26-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Dividend Updates

 Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 26, 2023, recommended the Final Dividend of Rs. 0.60 per equity share (face value of Rs. 2/- each) subject to approval of shareholders in the ensuing Annual General Meeting.
26-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Press Release / Media Release

 Pursuant to the relevant provisions of the SEBI Listing Regulations, we are enclosing herewith Press Release for Appointment of Dr. Shekhar Bhirud as President - Business Development, Strategy and R&D designated as Key Managerial Personnel of the Company w.e.f. May 26, 2023.
26-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Audited Financial Results For The Quarter And Year Ended March 31, 2023

 Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 26, 2023 considered and approved the Audited Financial Results for the Quarter and year ended March 31, 2023.
26-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Board Meeting Outcome for Outcome Of Board Meeting In Accordance With SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015

 Pursuant to Regulation 33 read with Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please be informed that the Board of Directors of the Company at its Meeting held on Friday, May 26, 2023, as attached
26-05-2023
Bigul

Annual report for Supriya Lifescience Ltd. for FY-2023
26-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Disclosure Under Regulation 30 Of Securities And Exchange Board Of India (Listing And Disclosure Requirements) Regulations, 2015

 In accordance with Regulation 30 of the SEBI (Listing Obligation and Disclosure Requirements) Regulations, 2015, we wish to inform you that we, Supriya Lifescience Limited have executed a long-term Supply and Sales Agreement (hereinafter 'Agreement') on May 23, 2023, with a leading Company in Europe for the supply of Active Pharmaceutical Ingredient (API) for a period of 10 years. The business potential would be approximately 400 Mn INR per year at its peak. The peak volumes are expected to happen in FY 27.
24-05-2023
Bigul

Supriya Lifescience Ltd - 543434 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

 Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, this is to inform you that an earnings call will be held on Monday, May 29, 2023 at 11.00 A.M. IST to discuss operational and financial performance of the Company for the fourth quarter and year ended March 31, 2023. The invite giving requisite details including the pre-registration link and dial-in details is attached herewith.
20-05-2023
Next Page
Close

Let's Open Free Demat Account